Agenus Inc. Files 2024 10-K

Ticker: AGEN · Form: 10-K · Filed: Mar 17, 2025 · CIK: 1098972

Sentiment: neutral

Topics: 10-K, biotech, financials

TL;DR

Agenus Inc. filed its 2024 10-K. Check financials.

AI Summary

Agenus Inc. filed its 2024 10-K on March 17, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Antigenics Inc. /DE/, is based in Lexington, MA, and operates in the biological products sector. Key financial details and operational aspects from the filing are not explicitly detailed in the provided text, but it references various accounting standards and company-specific tags.

Why It Matters

This filing provides stakeholders with a comprehensive overview of Agenus Inc.'s financial performance, strategic direction, and risk factors for the fiscal year 2024, crucial for investment decisions.

Risk Assessment

Risk Level: medium — The filing is a standard 10-K, but without specific financial details or business updates, assessing the precise risk level is difficult, though the nature of biotech can imply inherent risks.

Key Numbers

Key Players & Entities

FAQ

What is the primary business of Agenus Inc.?

Agenus Inc. operates in the Biological Products (No Diagnostic Substances) sector, SIC code 2836.

When did Agenus Inc. change its name from Antigenics Inc. /DE/?

The date of the name change was November 15, 1999.

What is the filing date of this 10-K report?

The 10-K report was filed on March 17, 2025.

What is the fiscal year end for this report?

The fiscal year end for this report is December 31, 2024.

What is the company's primary business address?

The company's business address is 3 Forbes Road, Lexington, MA 02421.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on March 17, 2025 regarding AGENUS INC (AGEN).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on Read The Filing